Direxion Daily S&P Biotech Bear 3X Shares LABD
7.08 USD -0.43 (-5.73%)
At closeNov 3, 2026, 4:32 PM EST
7.12 +0.04 +0.56%
After hours · Nov 3, 4:32 PM ET
6.80 Day range 7.42
5.81 52-week range 33.24
- YTD
- -66.38%
- 1 year
- -76.59%
- Market cap
- 17.17M
- YTD return
- -66.38%
- 1-year return
- -76.59%
- Volume
- 24.95M
- Avg volume
- 21.02M
- Open
- 7.37
- Previous close
- 7.51
- Day's range
- 6.80 – 7.42
- 52-week range
- 5.81 – 33.24
5Y -172.72 (-96.06%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 6.01
- 200-day average
- 6.90
About Direxion Daily S&P Biotech Bear 3X Shares
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
News
Top Performing Leveraged/Inverse ETFs: 10/18/2026
Investors Buy Large Volume of Put Options on Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD)
Top Performing Leveraged/Inverse ETFs: 09/13/2026
Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs
Top Performing Leveraged/Inverse ETFs: 05/11/2025
5 Leveraged/Inverse ETFs That Gained More Than 25% in April
Top Performing Leveraged/Inverse ETFs: 04/06/2025
Leveraged ETF Winners Amid Wall Street's Worst Week Since 2020
Top Performing Leveraged/Inverse ETFs: 11/17/2024 EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
Your note
Sign in to keep a note on LABD — it syncs with the Stock Master app.
